Vertically Integrated Cannabis Company With Products In 280 California Dispensaries And Joint Ventures, Licensing Agreement & Partnerships With Global Brands

Q4 2020 Performance Includes CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019

Sponsored
Hollister Biosciences Inc. Stock Quotes

For access to Time and Sales, you must have attained an Agoracom ranking of at least Treasurer.